Qualcomm Expands Collaboration with Novartis for Connected COPD Therapy

Qualcomm Life, Inc.Qualcomm Incorporated (NASDAQ: QCOM) today announced that its subsidiary, Qualcomm Life, Inc., and Novartis are expanding their global connected therapy management collaboration. Novartis will leverage Qualcomm Life's connectivity solutions to power its next-generation connected Breezhaler™, the inhaler for its Chronic Obstructive Pulmonary Disease (COPD) portfolio.

Qualcomm Life is developing the reference design for the small, low-power, disposable module to connect the next generation Breezhaler, which is part of Novartis' leading portfolio of COPD treatments comprised of Onbrez™, Seebri™ and Ultibro™, with Ultibro leading the category in the LABA/ LAMA therapy class. The module is designed to seamlessly connect with Qualcomm Life's 2net™ Platform, and can detect and report inhaler usage, as well as the duration of the patient's inhalation which indicates quality of the inhalation.

"This is an exciting time for health care as we see the proliferation of the Internet of Medical Things," said Rick Valencia, senior vice president and general manager, Qualcomm Life, Inc. "Through our expanded collaboration with Novartis, we are able to deliver a frictionless digital health experience to their COPD patients."

Through this collaboration, Novartis aims to be the first company with a completely integrated, connected delivery device that will provide a simple experience for patients, eliminate the need to assemble the device themselves, and enable them to more easily manage their chronic disease. With near-real time data capture from the patient and the connected device, Novartis aims to improve medication adherence and ultimately health outcomes for COPD patients.

Novartis plans to launch the new connected Breezhaler in 2019 following manufacturing, testing and regulatory approvals.

About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm's licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm's engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other.

2net is a trademark of Qualcomm Incorporated, registered in the United States and other countries.

Most Popular Now

Patient Care can Improve with Technology…

A significant part of the American Reinvestment and Recovery Act was the $25 billion invested in health information technology (IT) to improve quality, safety, efficiency in health care while also...

Read more

Medelinked Now Integrated with Microsoft…

Medelinked is now integrated with Microsoft Health and Band. The integration ensures that wellness summary data from Microsoft Health app and Band wearable is available in Medelinked to help users...

Read more

UK Health Show 2016 Partners with Highla…

GovNet Exhibitions has appointed Highland Marketing as its official partner to manage communications for the newly launched UK Health Show 2016. The show will bring together over 4,000 senior healthcare...

Read more

Seniors Embrace Social Technology

Contrary to popular belief, older adults enjoy emailing, instant messaging, Facebook and other forms of social technology. Not only that, but such online networking appears to reduce seniors' loneliness and...

Read more

Leading Digital Health Alliances Announc…

21 - 22 November 2016, Barcelona, Spain. The European Connected Health Alliance (ECHAlliance) and Personal Connected Health Alliance (PCHA) have signed a pivotal agreement to deliver key programme elements for the...

Read more

Big Data Europe Addresses Societal Chall…

Across society, from health to agriculture and transport, from energy to climate change and security, practitioners in every discipline recognise the potential of the enormous amounts of data being created...

Read more

Do Pokémon Go and augmented reality game…

The combination of augmented reality technology, geocaching, and other novel techniques to create innovative active video games (AVGs) has potential personal and public health implications, as discussed in the Editorial...

Read more

Nervecentre Launch Mobile Clinical Photo…

Nervecentre Software has launched a mobile clinical photography solution for nurses and doctors in hospitals. Fully integrated directly into the patient record, the mobile software is completely secure, compliant with...

Read more

in silico Clinical Trials: How Computer …

The term 'in silico clinical trials' refers to: "The use of individualised computer simulation in the development or regulatory evaluation of a medicinal product, medical device, or medical intervention...

Read more

Novartis Convenes Experts to Discuss New…

Novartis today opened the 13th International Biotechnology Leadership Camp (BioCamp). Over the course of three days more than 60 selected students from international universities will discuss and explore with biotechnology...

Read more

10th European Medical Information and Co…

29 - 30 November 2016, Berlin, Germany The 10th year of the Annual European Medical Information and Communications Conference is a unique meeting organised by medical information professionals for medical information...

Read more

Pfizer Launches New "Moodivator…

Pfizer Inc. (NYSE:PFE) has launched a new app, Moodivator, to help motivate and encourage the millions of adults who experience depression. Depression is one of the most common mental health...

Read more
(HEALTH IT) SPACE - Take a look at who has just Joined